Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
This is a multicentric International Phase III,Long term open label study(12 months)assessing the long-term safety and efficacy of BF2.649 (Pitolisant)in the treatment of Excessive Daytime Sleepiness (EDS) in narcoleptic patients with or without cataplexy.
Critère d'inclusion
- Narcolepsy ,Cataplexy